Financing Sustainable Drug Development for Neglected Diseases: A Case of Push-Pull Mechanisms and Global Public Goods
Neglected tropical diseases (NTDs) often afflict the poorest populations of the world. This observation suggests that while demands for new drugs against NTDs continue to grow, there is still a low profit margin for any innovation produced. As a result, there are few incentives for private industrial investments in drugs R&D for neglected diseases, and thus, urgent need for a new set of mechanisms to drive research towards these often 'forgotten' issues. One possible solution comes in the form of a collaborative partnership where drugs for neglected disease are seen by public, private and philanthropic organs as global public goods. In this scenario, multilateral collective action creates an artificial market where there are fewer risks for innovators and more results for benefactors. Coupled with policy-based push-pull mechanisms, these collaborations, like the Drugs for Neglected Diseases Initiative (DNDi), mitigate the challenges of a failed market and represents a paradigm for other potential sustainable development collaborations, post-2015.
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(02), pages 185-208, April.
- Toole, Andrew A., 2011. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," ZEW Discussion Papers 11-063, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research.
When requesting a correction, please mention this item's handle: RePEc:eso:journl:v:45:y:2014:i:2:p:245-259. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Martina Lawless)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.